Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Dividends and Buybacks
Dividend criteria checks 2/6
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical is a dividend paying company with a current yield of 0.8% that is well covered by earnings.
Key information
0.8%
Dividend yield
0.08%
Buyback Yield
| Total Shareholder Yield | 0.9% |
| Future Dividend Yield | n/a |
| Dividend Growth | 69.1% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | CN¥0.220 |
| Payout ratio | 88% |
Recent dividend and buyback updates
Recent updates
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd.'s (SZSE:300937) P/S Is Still On The Mark Following 48% Share Price Bounce
Nov 12
Capital Allocation Trends At Sichuan Hezong Medicine Easy-to-buy Pharmaceutical (SZSE:300937) Aren't Ideal
Sep 27Returns On Capital At Sichuan Hezong Medicine Easy-to-buy Pharmaceutical (SZSE:300937) Paint A Concerning Picture
Jun 07Sichuan Hezong Medicine Easy-to-buy Pharmaceutical's (SZSE:300937) Earnings Are Of Questionable Quality
Apr 17Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 300937 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 300937's dividend payments have increased, but the company has only paid a dividend for 4 years.
Dividend Yield vs Market
| Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (300937) | 0.8% |
| Market Bottom 25% (CN) | 0.6% |
| Market Top 25% (CN) | 2.2% |
| Industry Average (Consumer Retailing) | 1.9% |
| Analyst forecast (300937) (up to 3 years) | n/a |
Notable Dividend: 300937's dividend (0.8%) is higher than the bottom 25% of dividend payers in the CN market (0.53%).
High Dividend: 300937's dividend (0.8%) is low compared to the top 25% of dividend payers in the CN market (2.08%).
Earnings Payout to Shareholders
Earnings Coverage: At its current payout ratio (88.1%), 300937's payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (130.6%), 300937's dividend payments are not well covered by cash flows.